Clinical relevance of cytokine production in hemodialysis

Kidney International, Supplement

Volumn 58, Issue 76, 2000, Pages

  Pertosa, G ^a   Grandaliano, G ^a   Gesualdo, L ^a   Schena, F P ^a  

^a UNIVERSITY OF BARI   (Italy)

Author keywords

Biocompatibility; Cytokines; Hemodialysis complications

Indexed keywords

CYTOKINE; ERYTHROPOIETIN; INTERLEUKIN 1; INTERLEUKIN 6; PARATHYROID HORMONE; TUMOR NECROSIS FACTOR ALPHA; BIOMATERIAL;

ANEMIA; ARTICLE; BIOCOMPATIBILITY; BONE REMODELING; CELL ACTIVATION; CYTOKINE PRODUCTION; HEMODIALYSIS; HUMAN; IMMUNE RESPONSE; INFLAMMATION; MONONUCLEAR CELL; MORBIDITY; PATHOPHYSIOLOGY; PRIORITY JOURNAL; SLEEP DISORDER; BIOSYNTHESIS; CHRONIC KIDNEY FAILURE; IMMUNOLOGY; RENAL REPLACEMENT THERAPY; REVIEW;

BIOCOMPATIBLE MATERIALS; CYTOKINES; HUMANS; KIDNEY FAILURE, CHRONIC; RENAL DIALYSIS;

EID: 0033864557     PISSN: 00986577     EISSN: None     Source Type: Journal    
DOI: 10.1046/j.1523-1755.2000.07613.x     Document Type: Article

References (68)

1. Cytokine production in hemodialysis
2. Enhancement of reactive oxygen species production and cell surface markers expression due to hemodialysis
3. Enhanced production of nitric oxide by blood-dialysis membrane interaction
4. Cytokines and bioincompatibility
5. Clinical implications of hemodialysis membrane biocompatibility
6. Production of cytokines in hemodialysis
7. Cytokine relevance in biocompatibility
8. Secretory products of macrophages
9. Cytokines: Agents provocateurs in hemodialysis?
10. Cuprammonium membranes stimulate interleukin-1 release and arachidonic acid metabolism monocytes in the absence of complement
11. Transcription, not synthesis, of interleukin 1 and tumor necrosis factor by complement
12. C5b-9 generation and cytokine production in hemodialyzed patients
13. Effect of late complement components C5b-9 on human monocytes: Release of prostanoids, oxygen radicals and a factor inducing cell proliferation
14. Permeability of dialyzer membranes to TNFα-inducing substances derived from water bacteria
15. Endotoxins modulate chronically tumour necrosis factor alpha and interleukin 6 release by uraemic monocytes
16. Influence of hemodialysis on interleukin-6 production and gene expression by peripheral blood mononuclear cells
17. Impaired endotoxin-induced interleukin-1β secretion, not total production, of mononuclear cells from ESRD patients
18. Dialysis membranes decrease immunoglobulin and interleukin-6 production by peripheral blood mononuclear cells in vitro
19. Cytokine profiles during clinical high-flux dialysis: No evidence for cytokine generation by circulating monocytes
20. Balance between IL-1 beta, TNF-alpha and their specific inhibitors in chronic renal failure and maintenance dialysis: Relationship with activation markers of T cells, B cells and monocytes
21. The application of molecular biology techniques in the study of biocompatibility in hemodialysis
22. Interleukin-6, interleukin-8 and monocyte chemotactic peptide-1 gene expression and protein synthesis are independently modulated by hemodialysis membranes
23. Hemodialysis hypotension: The interleukin-1 hypothesis
24. Cytokines as endogenous pyrogens
25. Cytokines and fever: Mechanisms and sites of action
26. IL-6 and IL-1 beta in fever: Studies using cytokine-deficient (knockout) mice
27. The interleukin-1 type I receptor is expressed in human hypothalamus
28. Sleep complaints are common in a dialysis unit
29. Sleep: A physiologic role for IL-1 beta and TNF alpha
30. Somnogenic relationships between tumor necrosis factor and interleukin-1
31. Epidemiology of symptomatic hypotension in hemodialysis: Is cool dialysate beneficial for all patients?
32. Nitric oxide mediates the cardiovascular instability of hemodialysis patients
33. Enhancement of in-vitro human interleukin-1 production by sodium acetate
34. Acetate intolerance is mediated by enhanced synthesis of nitric oxide (NO) by endothelial cells
35. Effect of acetate, bicarbonate dialysis and acetate-free biofiltration on nitric oxide synthesis: Implications for dialysis hypotension
36. Elevated levels of inflammatory cytokines in bone marrow of patients with rheumatoid arthritis and anemia of chronic disease
37. Erythropoietin hyporesponsiveness: From iron deficiency to iron overload
38. Role of cytokines in the response to erythropoietin in hemodialysis patients
39. Inhibition of CFU-E colony formation in uremic patients with inflammatory disease: Role of IFN-gamma and TNF-alpha
40. STATs: Signal transducers and activators of transcription
41. Inhibitors keep cytokines in check
42. Interferons inhibit activation of STAT6 by interleukin 4 in human monocytes by inducing SOCS-1 gene expression
43. A distinct function of STAT proteins in erythropoietin signal transduction
44. Role of cytokines in renal osteodystrophy
45. Potential role of cytokines in renal osteodystrophy
46. A role for interleukin-6 in parathyroid hormone-induced bone resorption in vivo
47. Autocrine regulation of osteoclast formation and bone resorption by IL-1, TNF-α
48. 2+ signaling pathway in osteoblasts
49. The chemokine interleukin 8 regulates parathyroid secretion
50. Inhibition of PTH secretion by interleukin-1 beta in bovine parathyroid glands in vitro is associated with an up-regulation of the calcium-sensing receptor mRNA
51. Relationship between serum β2-microglobulin, bone histology and dialysis membranes in uraemic patients
52. 2m production and cellular expression
53. Effect of in vivo contact between blood and dialysis membranes on protein catabolism in humans
54. Mechanisms of malnutrition in uremia
55. Effect of in vivo contact between blood and dialysis membranes on protein catabolism in humans
56. Infusion of tumor necrosis factor: Cachectin promotes muscle catabolism in the rat
57. Proinflammatory cytokines, nutritional support and the cachexia syndrome: Interactions and therapeutic options
58. Interleukin-6 may mediate malnutrition in chronic hemodialysis patients
59. Cytokine production and nutritional status in hemodialysis patients
60. Infectious morbidity and defects of phagocytic function in end-stage renal disease: A review
61. Epidemiological perspective on infections in chronic dialysis
62. Immune dysfunction in uremia
63. Characteristic cytokine products of Th1 and Th2 cells in hemodialysis patients
64. Hemodialysis-related lymphomonuclear release of interleukin-12 in patients with end-stage renal disease
65. Cellular responses to interferon-γ
66. Effects of dialysis membrane on mortality of chronic hemodialysis patients
67. Immunological function and survival in hemodialysis patients